Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators

• Egile Nagusiak: Sheng Zhang (Egilea), Zhen-Qiang You (Egilea), Lin Yang (Egilea), Li-Li Li (Egilea), You-Ping Wu (Egilea), Li-Qiang Gu (Egilea), Yan-Fei Xin (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Doxorubicin (DOX) is a chemotherapy drug for malignant tumors. The clinical application of DOX is limited due to its dosage relative cardiotoxicity. Oxidative damage and cardiac inflammation appear to be involved in DOX-related cardiotoxicity. Shenmai injection (SMI), which mainl...